Member Info for inanaco

The problem is you are trying to interpret the vote ... rather than accepting the vote, which is exactly the same as the HOC ... which is why so many are getting into trouble ...
the question that is not asked of the Government is
why are they not following the party manifesto ...
and why are they potentially over turning the ref result
and why are they splitting off N ireland
so the complexity of all this is simple 70% of MP's want to stay in the EU
which is in conflict with the 52% ... so Mays deal is half in half out ....
lets assume you have another ref result 52% remain 48% leave ... would this result in a half in half out deal or remain ?
can you see the problem . The Elites are trying to over turn democracy ... its nothing now to do with the EU leave or remain ..
its """ is your vote worth anything """

The fundamental of the way the Economy and the future direction of the country is actually what is being discussed ...
You may be sick of it, but in terms of "everything" including Scancell it's massive ... so don't be naive ...

Andrea Leadsom a moment in time but feel she got in with the wrong crowd .... but i was bang on about this deal !! July ..
any way all fun and Games .. lays odds that it just might not make it to the vote, maybe at this point as leader of the house the paperwork goes missing ... with Andrea, Chatted with Hugo Swires, they are looking at a managed WTO exit way to much press, time and effort wasted on silly headlines .. but expect a bonanza once we are out, as the conservatives now have a few years to make this successful, but it needs vision at the top .. so a change of leader.
meanwhile UKIP have gone on training camps in Paris ..

Shareholders take the price down .... with thinking like this in the investment community Scancell does not stand a chance as pessimism drowns out optimism ... suppose thats is why remainers can never understand brexiteer optimists

will scrutinise the science behind the Bid ........ they are paying for a £30,000 report on the proposed project .. along with all the current research on moditope ...

what part of that is not going to give the SP confidence ?

when CRUK scientists will run a phase 1/2 on SCIB2

How odd ......... why would CRUK push them into the last 10 with that attitude ?

""" The reason I don’t get too exited about the GC is because I think there is a decent chance CRUK say to Biontech and Genentech - you people can afford to develop this yourselves, so stick your hand in your own pocket. We will see soon enough.. """

once cut they wilt ..

somebody is making Tosh's arguments ............

? ... £20m of research funding a distraction ? can't remember the exact figures but to date we have only spent about £25 m ... with another £10m still in the bank
I hope you fully understand that the most difficult to treat cancers are in this line up ... for Modi3 and pancreatic is probably the worse .. a treatment for that alone would be worth a fortune
Lindy talks of cures now, not the odd patient that just might respond .. but eye watering responses ... because we can hit patients with multiple moditope vaccines and personal vaccines all based around the moditope platform try and understand modi1, 2 , 3 are complementary vaccines that can even be used in combination to hit as many targets as possible. including TCR which probably the most potent, but the most expensive. for treating patients with very weak immune systems that have failed all other treatments ,,

Do you actually trust reports ? look at the bank of england ...

Mod1 is not a single target so it will have multiple shots on goal from the upcoming trial which is why the value is far higher

vaccine SCIB1 is .......

BioNtech continued collaboration is proving Moditope by a third party, which is why the value is going up everyday this continues, any failure would surely after a year would have come to light. The fact that they have not pulled out of the Modi3 program with CRUK also gives us confidence to the value that is building in the TCR area

IVy you are not comparing companies technology what you are comparing is efficacy ....

so for instance from Lindys mouse experiments we know that PD1 works in 55% of mice ..compared to 50% with scib1 but without side effect ...
combined 80%

that then compares with 100% with moditope ....

so yes you can compare technology but only look at the output

when the sp is falling we are actually valued by shareholders selling ...

its meaning less ..........

The only way is to put the IP up against competition on the same like for like basis which can be done

as we have no cash flow

that is a buy

point is you already have a withdrawal agreement, so its only the case of deleting text, not negotiating text so for instance all the citizens rights etc can be agreed in the no deal scenario ..

Its called a No deal transition .... which is why you have not seen recent resignations, so a deal can be quickly struck with the Eu to leave on WTO allowing both sides to gear up for it ...

the clue is in the name ... PCV ......... personal cancer vaccine

scancell TCR is a PCV

this 2010 vaccine does not exist ... it goes back to 1997 .. approx concentrate on the now .. Immunobody Tm. that is what we have developed